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Depression in diabetic patients as well as 
patients with chronic illnesses is still highly 
under-recognized and undertreated. In 
diabetic patients this has serious implications 
as depression can lead to poor glycaemic 
control as well as the development of 
complications and increased overall 
morbidity and mortality in these patients. It is 
therefore important that we institute 
screening programs to detect depression in 
these patients and institute the appropriate 
management in order to curb these outcomes. 
This would require a multidisciplinary 
approach and would require a dedicated team 
effort. The prevalence of Diabetes in 
Trinidad and Tobago is quite significant. This 
study highlights the need for development of 
protocols in our tertiary centres to address 
this important health concern. 
Results: The prevalence of depression in this subset of 
patients was found to be 46.2%. The patients were 
categorized according to their level of depression as 
follows: 35.1% had mild depression, 9.5% moderate 
depression and 1.5% had moderately severe depression. 
Males and females had similar prevalence. The majority of 
patients were of Indo Trinidadian descent (69.7%), 
married (61.8%) and worked in the public sector (42.3%).  
The factors independently associated with depression were 
highest level of education achieved (p=0.003), co-existing 
heart disease (p=0.048) and presence of myocardial 
infarction (p=0.040).  The more co morbidities a diabetic 
patient had, the more likely they were to be depressed 
(p=0.010).   
There was also a significant association between 
depression and glycaemic control. Patients who were 
depressed were more likely to have higher HbA1c% 
values and therefore poorer glycaemic control (p<0.0001).  
Patients who were depressed were less likely to adhere to 
meal plans (p=0.015) and exercise regimes (p=0.028). 
The World Health Organization (W.H.O) has established 
that depression is a significant contributor to the global 
burden of disease with an estimated 350 million people 
affected by depression worldwide (1).   It is projected to be 
the second highest cause of disability after heart disease by 
the year 2020 (2). Depression is highly under-recognized 
and under- diagnosed; for this reason only 30% of patients 
who have been identified, receive treatment (3). The 
prevalence of depression amongst patients with co morbid 
illnesses including Diabetes mellitus, Ischaemic heart 
disease, hypothyroidism and those with neurological 
disorders including stroke and epilepsy has been well 
established. It has also been shown that the more co-morbid 
conditions a patient has the more likely they are to be 
depressed (3, 4). A systematic review of the literature 
estimated that the prevalence of depression in America and 
European countries was 19.1 % amongst Type 2 diabetic 
patients. (5). 
This study investigated the prevalence of depression 
amongst diabetic patients presenting to an Emergency 
department (ED) setting in South West Trinidad as well as 
investigate whether depression has any effect or relation on 
glycaemic control in these patients. As previously 
mentioned the prevalence of depression is highly 
unrecognized and therefore undertreated (3). Screening for 
depression has been done in the primary care setting as well 
as in an Emergency department setting in this country (7, 9).  
However the previous Emergency department study only 
included elderly patients (defined as ≥ 65 years of age). The 
majority of local studies as well as those done in the 
Caribbean were undertaken in a primary care setting. This 
study was the first of its kind evaluating the impact of 
depression on clinical outcomes in Diabetic patients 
presenting to an Emergency department in a tertiary care 
setting in Trinidad and Tobago and the Caribbean. Tertiary 
care emergency departments may be the first medical 
contact for many of these patients and hence are a good 
avenue for screening for depression in these patients.  
The aim of this study was to determine the prevalence of 
undiagnosed depression amongst diabetic patients 
presenting to a tertiary care Emergency department. The 
other objectives were to investigate the impact of depression 
on these patients with respect to concurrent co morbidities, 
glycaemic control and compliance to self-care activities. 
A cross-sectional study was done at a tertiary care 
Emergency department in South West Trinidad during the 
time period October 1st to December 31st 2014. Type 2 
Diabetic patients who consented to participate in the study 
were given self-administered questionnaires pertaining to 
their diabetes and self-care as well as a self-administered 
depression module the PHQ-9. Chi-square testing, non-
parametric tests and logistic and linear regression modules 
were used to determine if there were any associations 
between depression and demographic data, co-existing co 
morbidities glycaemic control and compliance with self- 
care regimes.   
Demographics 
  
Total 390 Overall 
%(of population) 
Not Depressed (%) Depressed 
(%) 
P value⃰ 
  N=390   53.8 46.2   
Gender Male 
Female 
191 (49.0) 
199 (51.0) 
107 (56.0) 
103 (51.8) 
84 (44.0) 
96 (48.2) 
0.399 
Ethnicity African 
East Indian 
Chinese/ Mixed 
114 (29.2) 
272 (69.7) 
4 (1.1) 
69 (60.5) 
140 (51.5) 
1 (25.0) 
45 (39.5) 
132 (48.5) 
3 (75.0)   
0.162 
Marital status Married 
Single 
Divorced/separated 
Common Law 
Widowed 
241 (61.8) 
52 (13.1) 
27 (6.9) 
15 (3.8) 
56 (14.4) 
139 (57.7) 
28 (54.9) 
10 (37.0) 
8 (53.3) 
25 (43.9) 
102 (42.3) 
23 (45.1) 
17 (63.0) 
7 (46.7) 
31.9(56.1) 
0.170 
Occupation Domestic 
Private Sector 
Public Sector 
Retired 
27 (30.5) 
18 (4.6) 
165 (42.3) 
88 (22.3) 
58 (48.7) 
9 (50.0) 
95 (57.6) 
48 (54.5) 
61 (51.3) 
9 (50.0)  
70 (42.4) 
40 (45.5) 
  
0.003 
HbA1c% 
  
Normal < 6.5 
Abnormal ≥ 6.5 
241 (61.8) 
149 (38.2) 
176 (73.0) 
34 (22.8) 
65 (27.0)  
115 (77.2) 
  
<0.0001 
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